Literature DB >> 18683917

The alkaloid conessine and analogues as potent histamine H3 receptor antagonists.

Chen Zhao1, Minghua Sun, Youssef L Bennani, Sujatha M Gopalakrishnan, David G Witte, Thomas R Miller, Kathleen M Krueger, Kaitlin E Browman, Christine Thiffault, Jill Wetter, Kennan C Marsh, Arthur A Hancock, Timothy A Esbenshade, Marlon D Cowart.   

Abstract

The naturally occurring alkaloid, conessine (6), was discovered to bind to histamine H3 receptors in a radioligand-based high-throughput screen. Conessine displayed high affinity at both rat and human H3 receptors (pKi = 7.61 and 8.27) and generally high selectivity against other sites, including histamine receptors H1, H2, and H4. Conessine was found to efficiently penetrate the CNS and reach very high brain concentrations. Although the very slow CNS clearance and strong binding to adrenergic receptors discouraged focus on conessine itself for further development, its potency and novel steroid-based skeleton motivated further chemical investigation. Modification based on introducing diversity at the 3-nitrogen position generated a new series of H3 antagonists with higher in vitro potency, improved target selectivity, and more favorable drug-like properties. One optimized analogue (13c) was examined in detail and was found to be efficacious in animal behavioral model of cognition.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18683917     DOI: 10.1021/jm8003625

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  11 in total

Review 1.  Structural features of mammalian histidine decarboxylase reveal the basis for specific inhibition.

Authors:  A A Moya-García; A Pino-Angeles; R Gil-Redondo; A Morreale; F Sánchez-Jiménez
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

2.  Total Synthesis (+)-7-Bromotrypargine and Unnatural Analogs: Biological Evaluation Uncovers Activity at CNS Targets of Therapeutic Relevance.

Authors:  John T Brogan; Sydney L Stoops; Brenda C Crews; Lawrence J Marnett; Craig W Lindsley
Journal:  ACS Chem Neurosci       Date:  2011-11-16       Impact factor: 4.418

3.  Total synthesis and biological evaluation of phidianidines A and B uncovers unique pharmacological profiles at CNS targets.

Authors:  John T Brogan; Sydney L Stoops; Craig W Lindsley
Journal:  ACS Chem Neurosci       Date:  2012-06-27       Impact factor: 4.418

Review 4.  International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors.

Authors:  Pertti Panula; Paul L Chazot; Marlon Cowart; Ralf Gutzmer; Rob Leurs; Wai L S Liu; Holger Stark; Robin L Thurmond; Helmut L Haas
Journal:  Pharmacol Rev       Date:  2015-07       Impact factor: 25.468

Review 5.  Therapeutic Potential of Histamine H3 Receptors in Substance Use Disorders.

Authors:  Patricia Di Ciano; Christian S Hendershot; Bernard Le Foll
Journal:  Curr Top Behav Neurosci       Date:  2022

6.  Chemical Probes for Histamine Receptor Subtypes.

Authors:  Markus Falkenstein; Milica Elek; Holger Stark
Journal:  Curr Top Behav Neurosci       Date:  2022

7.  Novel chalcone-based fluorescent human histamine h(3) receptor ligands as pharmacological tools.

Authors:  Miriam Tomasch; J Stephan Schwed; Lilia Weizel; Holger Stark
Journal:  Front Syst Neurosci       Date:  2012-03-26

8.  Ciproxifan, a histamine H3 receptor antagonist, reversibly inhibits monoamine oxidase A and B.

Authors:  S Hagenow; A Stasiak; R R Ramsay; H Stark
Journal:  Sci Rep       Date:  2017-01-13       Impact factor: 4.379

9.  Conessine Interferes with Oxidative Stress-Induced C2C12 Myoblast Cell Death through Inhibition of Autophagic Flux.

Authors:  Hyunju Kim; Kang Il Lee; Minsu Jang; Sim Namkoong; Rackhyun Park; Hyunwoo Ju; Inho Choi; Won Keun Oh; Junsoo Park
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

Review 10.  Metabolic Diversity and Therapeutic Potential of Holarrhena pubescens: An Important Ethnomedicinal Plant.

Authors:  Kulsoom Zahara; Sujogya Kumar Panda; Shasank Sekhar Swain; Walter Luyten
Journal:  Biomolecules       Date:  2020-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.